Recombinant Interleukin-2: Clinical Trials

3 trials of Recombinant Interleukin-2, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3

Follow Recombinant Interleukin-2: new trials by email Literature Review of Recombinant Interleukin-2 trials Research Report on Recombinant Interleukin-2

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia
cytarabine, daunorubicin hydrochloride, etoposide - Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia
Phase 3CompletedNational Cancer Institute (NCI)7202000-11-012013-06-04
Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
asparaginase, daunorubicin hydrochloride, fludarabine phosphate - Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7)
Phase 3CompletedNational Cancer Institute (NCI)8801996-08-012013-01-16
Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
aldesleukin, filgrastim, cyclophosphamide - Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma
Phase 3CompletedNational Cancer Institute (NCI)2061995-05-012013-02-28

Conditions studied

Anemia, Refractory (1)  ·  Anemia, Refractory, with Excess of Blasts (1)  ·  Burkitt Lymphoma (1)  ·  Congenital Abnormalities (1)  ·  Leukemia, Basophilic, Acute (1)  ·  Leukemia, Eosinophilic, Acute (1)  ·  Leukemia, Erythroblastic, Acute (1)  ·  Leukemia, Megakaryoblastic, Acute (1)  ·  Leukemia, Monocytic, Acute (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Leukemia, Myelomonocytic, Acute (1)  ·  Leukemia, Myelomonocytic, Chronic (1)  ·  Lymphoma, Follicular (1)  ·  Lymphoma, Large B-Cell, Diffuse (1)  ·  Lymphoma, Large-Cell, Immunoblastic (1)

Sponsors

National Cancer Institute (NCI) (3)

Countries

United States (3)

Top investigators

Beverly Lange (1)  ·  John Thompson (1)  ·  Jonathan Kolitz (1)

Results publications

PMID 18256325, PMID 19304957, PMID 20056794, PMID 20413658, PMID 20522709, PMID 31375516, PMID 36184192, PMID 36815378, PMID 38295280, PMID 42085603

NIH funding

U10CA031946 (1), U10CA032102 (1), U10CA098543 (1)